Cited by 72Drug Transport and Resistance MechanismsPharmacogenetics and Drug MetabolismPorphyrin Metabolism and Disorders

In Vitro Evaluation of Photosensitivity Risk Related to Genetic Polymorphisms of Human ABC Transporter ABCG2 and Inhibition by Drugs

Tamura, Ai, Onishi, Yuko, An, Ran, Koshiba, Shoko, Wakabayashi, Kanako, Hoshijima, Kazuyuki, Priebe, Waldemar, Yoshida, Takashi +4 more·2007·Drug Metabolism and Pharmacokinetics

Abstract

Since porphyrins are regarded as endogenous substrates for the ATP-binding cassette (ABC) transporter ABCG2, it is hypothesized that functional impairment owing to genetic polymorphisms or inhibition of ABCG2 by drugs may result in a disruption of cellular porphyrin homeostasis. In the present study, we expressed ABCG2 genetic variants, i.e., V12M, Q141K, S441N, and F489L, as well as the wild type (WT) in Flp-In-293 cells to examine the hypothesis. Cells expressing S441N and F489L variants exhibited high levels of both cellularly accumulated pheophorbide a and photosensitivity, when those cells were incubated with pheophorbide a and irradiated with visible light. To further elucidate the significance of ABCG2 in cellular porphyrin homeostasis, we observed cellular accumulation and compartmentation of porphyrin and pheophorbide a by means of a new fluorescence microscopy technology, and found that accumulation of porphyrin and pheophorbide a in the cytoplasm compartment was maintained at low levels in Flp-In-293 cells expressing ABCG2 WT, V12M, or Q141K. When ABCG2 was inhibited by imatinib or novobiocin, however, those cells became sensitive to light. Based on these results, it is strongly suggested that certain genetic polymorphisms and/or inhibition of ABCG2 by drugs can enhance the potential risk of photosensitivity.

Integrity signals

Registry

Crossref · 10.2133/dmpk.22.428

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tamura, A., Onishi, Y., An, R., Koshiba, S., Wakabayashi, K., Hoshijima, K., Priebe, W., Yoshida, T., Kometani, S., Matsubara, T., Mikuriya, K., & Ishikawa, T.
Affiliations
  • Tokyo Institute of Technology (JP)
  • The University of Texas MD Anderson Cancer Center (US)
  • Yokogawa Electric (Japan) (JP)
Corresponding author
Ishikawa, Toshihisa
Venue
Drug Metabolism and Pharmacokinetics
Published
2007
Volume
22
Issue
6
Pages
428-440
ISSN
1347-4367 (ISSN-L)
OpenAlex
W2051086992
Cited by
72
References
3
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 6
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Metabolism and Pharmacokinetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
Keywords
ABCG2, photosensitivity, genetic polymorphism, pheophorbide a, ABC transporter inhibition, imatinib, novobiocin, porphyrin accumulation
MeSH terms
Imatinib Mesylate, ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Benzamides, Cell Line, Cell Survival, Chlorophyll, Dose-Response Relationship, Drug, Drug Interactions, Homeostasis, Humans, Insecta, Light, Microscopy, Fluorescence, Neoplasm Proteins, Novobiocin, Photosensitivity Disorders, Piperazines, Porphyrins, Pyrimidines, Quercetin, Transfection, Photosensitizing Agents, ATP-Binding Cassette Transporters, Risk Assessment, Inhibitory Concentration 50, Polymorphism, Single Nucleotide, Membrane Transport Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review